You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 64 No. 4, April 2007 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (93)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Alzheimer Disease
 •Cognitive Disorders
 •Dementias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Relation of Diabetes to Mild Cognitive Impairment

José A. Luchsinger, MD; Christiane Reitz, MD; Bindu Patel, MPH; Ming-Xin Tang, PhD; Jennifer J. Manly, PhD; Richard Mayeux, MD

Arch Neurol. 2007;64(4):570-575.

Background  Type 2 diabetes mellitus is an important risk factor for Alzheimer disease and is more prevalent in elderly minority persons compared with non-Hispanic white persons.

Objective  To determine whether diabetes is related to a higher risk of mild cognitive impairment (MCI), a transitional stage between normal cognition and Alzheimer disease, in a multiethnic cohort with a high prevalence of diabetes.

Design  Longitudinal cohort study.

Setting  Northern Manhattan in New York, NY.

Participants  We studied persons without prevalent MCI or dementia at baseline and with at least 1 follow-up interval. Of 1772 participants with a complete neuropsychological evaluation, 339 (19.1%) were excluded because of prevalent dementia, 304 were excluded because of prevalent MCI (17.2%), and 211 were excluded because of loss to follow-up (11.9%), resulting in a final sample of 918 participants for longitudinal analyses.

Main Outcome Measures  We related diabetes defined by self-report to incident all-cause MCI, amnestic MCI, and nonamnestic MCI. We conducted multivariate analyses with proportional hazards regression adjusting for age, sex, years of education, ethnic group, apolipoprotein E (APOE) {varepsilon}4 allele, hypertension, low-density lipoprotein level, current smoking, heart disease, and stroke.

Results  A total of 334 persons had incident MCI, 160 (47.9%) had amnestic MCI, and 174 (52.1%) had nonamnestic MCI. Diabetes was related to a significantly higher risk of all-cause MCI and amnestic MCI after adjustment for all covariates. Diabetes was also related to a higher risk of nonamnestic MCI, but this association was appreciably attenuated after adjustment for socioeconomic variables and vascular risk factors. The risk of MCI attributable to diabetes was 8.8% for the whole sample and was higher for African American persons (8.4%) and Hispanic persons (11.0%) compared with non-Hispanic white persons (4.6%), reflecting the higher prevalence of diabetes in minority populations in the United States.

Conclusion  Diabetes is related to a higher risk of amnestic MCI in a population with a high prevalence of this disorder.


Author Affiliations: Taub Institute for Research of Alzheimer's Disease and the Aging Brain (Drs Luchsinger, Tang, Manly, and Mayeux and Ms Patel), Gertrude H. Sergievsky Center (Drs Luchsinger, Reitz, Manly, and Mayeux), and Departments of Biostatistics (Dr Tang) and Epidemiology (Drs Luchsinger and Mayeux), Joseph P. Mailman School of Public Health; and Departments of Medicine (Dr Luchsinger), Neurology (Drs Manly and Mayeux), and Psychiatry (Dr Mayeux), College of Physicians and Surgeons, Columbia University, New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topiramate Treatment Protects Blood-Brain Barrier Pericytes from Hyperglycemia-Induced Oxidative Damage in Diabetic Mice
Price et al.
Endocrinology 2012;153:362-372.
ABSTRACT | FULL TEXT  

Cerebrovascular lesions induce transient {beta}-amyloid deposition
Garcia-Alloza et al.
Brain 2011;134:3697-3707.
ABSTRACT | FULL TEXT  

Vascular risk factors and cognitive impairment in a stroke-free cohort
Unverzagt et al.
Neurology 2011;77:1729-1736.
ABSTRACT | FULL TEXT  

Influence of Reading Ability on Neuropsychological Performance in African American Elders
Schneider and Lichtenberg
Arch Clin Neuropsychol 2011;26:624-631.
ABSTRACT | FULL TEXT  

Why Physiology Matters in Medicine
Joyner
Physiology 2011;26:72-75.
FULL TEXT  

Atrial fibrillation and incidence of dementia: A systematic review and meta-analysis
Kwok et al.
Neurology 2011;76:914-922.
ABSTRACT | FULL TEXT  

Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
Xu et al.
Diabetes 2010;59:2928-2935.
ABSTRACT | FULL TEXT  

A Summary Risk Score for the Prediction of Alzheimer Disease in Elderly Persons
Reitz et al.
Arch Neurol 2010;67:835-841.
ABSTRACT | FULL TEXT  

Cognitive decline: the relevance of diabetes, hyperlipidaemia and hypertension
Etgen et al.
British Journal of Diabetes & Vascular Disease 2010;10:115-122.
ABSTRACT  

Cranial Volume, Mild Cognitive Deficits, and Functional Limitations Associated with Diabetes in a Community Sample
Christman et al.
Arch Clin Neuropsychol 2010;25:49-59.
ABSTRACT | FULL TEXT  

Risk of developing dementia in people with diabetes and mild cognitive impairment
Velayudhan et al.
Br. J. Psychiatry 2010;196:36-40.
ABSTRACT | FULL TEXT  

Differences in Brain Volume, Hippocampal Volume, Cerebrovascular Risk Factors, and Apolipoprotein E4 Among Mild Cognitive Impairment Subtypes
He et al.
Arch Neurol 2009;66:1393-1399.
ABSTRACT | FULL TEXT  

Subclinical cerebrovascular disease in mild cognitive impairment
Luchsinger et al.
Neurology 2009;73:450-456.
ABSTRACT | FULL TEXT  

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Chen et al.
Proc. Natl. Acad. Sci. USA 2009;106:3907-3912.
ABSTRACT | FULL TEXT  

Mediterranean Diet and Mild Cognitive Impairment
Scarmeas et al.
Arch Neurol 2009;66:216-225.
ABSTRACT | FULL TEXT  

Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study
Saczynski et al.
Am J Epidemiol 2008;168:1132-1139.
ABSTRACT | FULL TEXT  

Predictors of Cognitive Decline in Older Individuals With Diabetes
Bruce et al.
Diabetes Care 2008;31:2103-2107.
ABSTRACT | FULL TEXT  

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
Beeri et al.
Neurology 2008;71:750-757.
ABSTRACT | FULL TEXT  

Association of Duration and Severity of Diabetes Mellitus With Mild Cognitive Impairment
Roberts et al.
Arch Neurol 2008;65:1066-1073.
ABSTRACT | FULL TEXT  

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Nonpharmacological Cognitive Interventions in Aging and Dementia
Acevedo and Loewenstein
J Geriatr Psychiatry Neurol 2007;20:239-249.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.